← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Fibralign Corporation
Union City, CA
$3,145,678
Total funding
2
Grants
Funding over time
peak $998.2K · FY2013–21$1M$750K$500K$250K$0
'13
'14
'15
'16
'17
'18
'19
'20
'21
Funding mix
By agency
NIH$2,965,714 · 1
NSF$179,964 · 1
By mechanism
R44$2,965,714 · 1
—$179,964 · 1
Investigators at Fibralign Corporation
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
All-Time
Most funded here, all years
Largest grants
Prospective evaluation of a surgical solution for breast cancer-associated lymphedema$998,174
R44 · FY2018 · CA
Prospective evaluation of a surgical solution for breast cancer-associated lymphedema$997,783
R44 · FY2017 · CA
Prospective evaluation of a surgical solution for breast cancer-associated lymphedema$682,266
R44 · FY2021 · CA
Prospective evaluation of a surgical solution for breast cancer-associated lymphedema$252,861
R44 · FY2019 · CA
SBIR Phase I: Nanofibrillar Scaffolds for Tissue Engineering$179,964
· FY2013 · TIP
Prospective evaluation of a surgical solution for breast cancer-associated lymphedema$32,935
R44 · FY2020 · CA
Prospective evaluation of a surgical solution for breast cancer-associated lymphedema$1,695
R44 · FY2019 · CA